is semaglutide better than tirzepatide for weight loss vs Semaglutide vs Tirzepatide: Which GLP-1

Mounjaro and Zepbound both contain tirzepatide, a dual GIP and GLP-1 receptor agonist

roughly 83% of quit attempts result in relapse within six months, and 89% do so within a year

doi: 10.1111/J.1445-5994.1991.TB01375.X 19 LupiRDel GuerraSFierabracciVMarselliLNovelliMPatanGet al

For GI-focused use cases, oral delivery may appear more intuitive because the compound passes directly through the digestive tract and makes contact with the tissue it was originally studied in relation to

Current evidence suggests that GLP-1 receptor agonists are not only safe for patients with fatty liver disease but may offer specific hepatic benefits beyond weight loss alone

Onge, University of Florida, United States Updates Copyright 2024 Niu, Fan, Gao, Chen and Dai